Gossamer Net Debt from 2010 to 2025

GOSS Stock

USD 1.39 0.04 2.96%

Gossamer Bio Net Debt yearly trend continues to be comparatively stable with very little volatility. Net Debt is likely to outpace its year average in 2025. Net Debt is the total debt of Gossamer Bio minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2017-12-31

Previous Quarter

175.2 M

Current Value

156.8 M

Quarterly Volatility

162.8 M

Covid

Check Gossamer Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Gossamer Bio's main balance sheet or income statement drivers, such as Interest Income of 1.6 M, Interest Expense of 8.7 M or Selling General Administrative of 36.8 M, as well as many indicators such as Price To Sales Ratio of 1.42, Dividend Yield of 0.0 or PTB Ratio of 7.29. Gossamer financial statements analysis is a perfect complement when working with Gossamer Bio Valuation or Volatility modules.

Check out the analysis of Gossamer Bio Correlation against competitors.

For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.

Latest Gossamer Bio's Net Debt Growth Pattern

Below is the plot of the Net Debt of Gossamer Bio over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Gossamer Bio's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Gossamer Bio's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Gossamer Net Debt Regression Statistics

	Arithmetic Mean	7,494,712
	Geometric Mean	1,866,164
	Coefficient Of Variation	1,571
	Mean Deviation	73,199,819
	Median	(20,000)
	Standard Deviation	117,729,582
	Sample Variance	13860.3T
	Range	482.7M
	R-Value	0.33
	Mean Square Error	13190.9T
	R-Squared	0.11
	Significance	0.21
	Slope	8,266,104
	Total Sum of Squares	207903.8T

Gossamer Net Debt History

	2025	164.6 M
	2024	156.8 M
	2023	180.4 M
	2022	113.8 M
	2021	1.8 M
	2020	-302.3 M
	2019	-95.5 M

Other Fundumenentals of Gossamer Bio

Net Debt To E B I T D A

Gossamer Bio Net Debt component correlations

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Long Term Debt Total	Total Liab	Total Current Assets	Capital Surpluse	Net Invested Capital	Net Working Capital	Net Receivables	Deferred Long Term Liab	Capital Stock	Common Stock	Property Plant Equipment	Short Term Debt	Short Long Term Debt
Total Assets		-0.55	0.66	-0.19	-0.72	0.83	0.77	0.92	0.77	1.0	0.85	0.89	1.0	0.42	-0.26	0.57	0.57	0.56	0.26	-0.26
Total Stockholder Equity	-0.55		-0.44	0.24	0.34	-0.35	-0.55	-0.47	-0.43	-0.55	-0.54	-0.55	-0.53	-0.04	-0.22	0.02	0.02	-0.27	-0.41	-0.22
Net Tangible Assets	0.66	-0.44		-0.53	-0.16	0.45	0.25	0.35	0.03	0.65	0.44	0.81	0.67	-0.11	0.09	0.07	0.07	0.79	-0.04	0.09
Net Debt	-0.19	0.24	-0.53		-0.51	-0.2	0.29	0.12	0.12	-0.18	0.25	-0.11	-0.21	0.74	-0.48	0.6	0.6	-0.26	0.35	-0.48
Retained Earnings	-0.72	0.34	-0.16	-0.51		-0.65	-0.94	-0.85	-0.77	-0.72	-0.92	-0.69	-0.7	-0.87	0.58	-0.92	-0.92	-0.14	-0.47	0.58
Accounts Payable	0.83	-0.35	0.45	-0.2	-0.65		0.77	0.72	0.7	0.83	0.72	0.75	0.83	0.32	-0.17	0.54	0.54	0.14	0.36	-0.17
Long Term Debt	0.77	-0.55	0.25	0.29	-0.94	0.77		0.83	0.8	0.78	0.95	0.75	0.75	0.7	-0.35	0.76	0.76	0.07	0.55	-0.35
Long Term Debt Total	0.92	-0.47	0.35	0.12	-0.85	0.72	0.83		0.9	0.92	0.86	0.73	0.91	0.64	-0.45	0.73	0.73	0.42	0.31	-0.45
Total Liab	0.77	-0.43	0.03	0.12	-0.77	0.7	0.8	0.9		0.77	0.73	0.46	0.75	0.56	-0.32	0.61	0.61	0.06	0.38	-0.32
Total Current Assets	1.0	-0.55	0.65	-0.18	-0.72	0.83	0.78	0.92	0.77		0.85	0.89	1.0	0.42	-0.26	0.58	0.58	0.55	0.26	-0.26
Capital Surpluse	0.85	-0.54	0.44	0.25	-0.92	0.72	0.95	0.86	0.73	0.85		0.86	0.82	0.69	-0.33	0.77	0.77	0.34	0.49	-0.33
Net Invested Capital	0.89	-0.55	0.81	-0.11	-0.69	0.75	0.75	0.73	0.46	0.89	0.86		0.88	0.4	-0.23	0.56	0.56	0.59	0.29	-0.23
Net Working Capital	1.0	-0.53	0.67	-0.21	-0.7	0.83	0.75	0.91	0.75	1.0	0.82	0.88		0.4	-0.29	0.57	0.57	0.57	0.21	-0.29
Net Receivables	0.42	-0.04	-0.11	0.74	-0.87	0.32	0.7	0.64	0.56	0.42	0.69	0.4	0.4		-0.69	0.91	0.91	0.05	0.46	-0.69
Deferred Long Term Liab	-0.26	-0.22	0.09	-0.48	0.58	-0.17	-0.35	-0.45	-0.32	-0.26	-0.33	-0.23	-0.29	-0.69		-0.77	-0.77	-0.03	0.25	1.0
Capital Stock	0.57	0.02	0.07	0.6	-0.92	0.54	0.76	0.73	0.61	0.58	0.77	0.56	0.57	0.91	-0.77		1.0	0.12	0.26	-0.77
Common Stock	0.57	0.02	0.07	0.6	-0.92	0.54	0.76	0.73	0.61	0.58	0.77	0.56	0.57	0.91	-0.77	1.0		0.12	0.26	-0.77
Property Plant Equipment	0.56	-0.27	0.79	-0.26	-0.14	0.14	0.07	0.42	0.06	0.55	0.34	0.59	0.57	0.05	-0.03	0.12	0.12		-0.06	-0.03
Short Term Debt	0.26	-0.41	-0.04	0.35	-0.47	0.36	0.55	0.31	0.38	0.26	0.49	0.29	0.21	0.46	0.25	0.26	0.26	-0.06		0.25
Short Long Term Debt	-0.26	-0.22	0.09	-0.48	0.58	-0.17	-0.35	-0.45	-0.32	-0.26	-0.33	-0.23	-0.29	-0.69	1.0	-0.77	-0.77	-0.03	0.25

Click cells to compare fundamentals

About Gossamer Bio Financial Statements

Gossamer Bio shareholders use historical fundamental indicators, such as Net Debt, to determine how well the company is positioned to perform in the future. Although Gossamer Bio investors may analyze each financial statement separately, they are all interrelated. The changes in Gossamer Bio's assets and liabilities, for example, are also reflected in the revenues and expenses on on Gossamer Bio's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	156.8 M	164.6 M
Net Debt To EBITDA	(3.92)	(3.73)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Gossamer Stock Analysis

When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Gossamer Net Debt from 2010 to 2025

Latest Gossamer Bio's Net Debt Growth Pattern

Gossamer Net Debt Regression Statistics

Gossamer Net Debt History

Other Fundumenentals of Gossamer Bio

Gossamer Bio Net Debt component correlations

About Gossamer Bio Financial Statements

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Gossamer Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY